2026 Q2 Portfolio Activity
In 2026 Q2, Affinity Asset Advisors, LLC maintained a portfolio of 131 distinct positions. The most significant new addition was ARK ETF TR, now representing 1.43% of the total fund value. They heavily accumulated shares in ROIVANT SCIENCES LTD, increasing the position by 33.9%. Conversely, Affinity Asset Advisors, LLC completely exited their position in STATE STR SPDR S&P 500 ETF T.
Position History
hover any row below to update
Loading…
Total Positions
131
Quarter
2026 Q2
Top Holding
ROIV (6.0%)
Top 10 Concentration
39.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 131
Affinity Asset Advisors, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 6.00% | 4.01% |
#1
5
Prev: #6
|
6.9 |
—
|
950,000 | 33.9% |
P
S
|
3,750,000 | $132,712,500 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 5.92% | 5.59% |
#2
Prev: #2
|
3.9 |
—
|
-297,926 | -23.2% |
P
S
|
987,000 | $131,004,510 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 5.13% | 3.33% |
#3
4
Prev: #7
|
4.1 |
—
|
no change | no change |
P
S
|
1,279,134 | $113,561,517 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 4.35% | 5.03% |
#4
1
Prev: #3
|
2.7 |
—
|
-80,000 | -4.8% |
P
S
|
1,595,000 | $96,274,200 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ERAS
ERASCA INC
|
Healthcare | 4.35% | 4.47% |
#5
1
Prev: #4
|
2.7 |
—
|
-100,000 | -1.9% |
P
S
|
5,250,000 | $96,180,000 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INSM
INSMED INC
|
Healthcare | 3.13% | 4.05% |
#6
1
Prev: #5
|
3.8 |
—
|
170,000 | 35.4% |
P
S
|
650,000 | $69,303,000 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 2.80% | 2.83% |
#7
2
Prev: #9
|
3.1 |
—
|
15,000 | 8.8% |
P
S
|
185,000 | $61,936,150 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 2.66% | 2.47% |
#8
3
Prev: #11
|
1.6 |
—
|
-225,000 | -16.7% |
P
S
|
1,125,000 | $58,944,375 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 2.54% | 1.27% |
#9
16
Prev: #25
|
3.0 |
—
|
90,327 | 18.1% |
P
S
|
590,000 | $56,150,300 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ANAB
ANAPTYSBIO INC
|
Healthcare | 2.52% | 2.69% |
#10
Prev: #10
|
1.5 |
—
|
-113,891 | -12.1% |
P
S
|
826,109 | $55,762,358 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 2.42% | 1.03% |
#11
20
Prev: #31
|
4.0 |
—
|
1,559,160 | 116.3% |
P
S
|
2,900,000 | $53,592,000 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.12% | 2.38% |
#12
Prev: #12
|
0.8 |
—
|
-150,483 | -21.5% |
P
S
|
550,000 | $46,854,500 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.12% | 0.50% |
#13
39
Prev: #52
|
3.8 |
—
|
150,000 | 150.0% |
P
S
|
250,000 | $46,820,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.99% | 2.33% |
#14
1
Prev: #13
|
1.3 |
—
|
-75,000 | -18.5% |
P
S
|
330,000 | $43,975,800 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
FIRST TRACKS BI...
|
|
Unknown | 1.85% | — |
#15
Prev: #—
|
4.2 |
—
|
2,032,012 | — |
NEW
|
2,032,012 | $40,884,081 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.76% | 1.52% |
#16
3
Prev: #19
|
2.7 |
—
|
50,000 | 14.3% |
P
S
|
400,000 | $38,992,000 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 1.76% | 1.38% |
#17
6
Prev: #23
|
2.7 |
—
|
102,968 | 9.6% |
P
S
|
1,172,487 | $38,926,568 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 1.58% | — |
#18
Prev: #—
|
4.1 |
—
|
500,000 | — |
NEW
|
500,000 | $35,015,000 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 1.54% | 1.59% |
#19
2
Prev: #17
|
1.1 |
—
|
-25,000 | -8.3% |
P
S
|
275,000 | $33,962,500 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 1.52% | 1.23% |
#20
6
Prev: #26
|
1.1 |
—
|
-200,000 | -10.0% |
P
S
|
1,800,172 | $33,573,208 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MRNA
CALL
MODERNA INC
|
CALL Option | 1.50% | 2.10% |
#21
5
Prev: #16
|
0.6 |
—
|
-325,000 | -40.6% |
P
S
|
475,000 | $33,264,250 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARKG
CALL
ARK ETF TR
|
CALL Option | 1.43% | — |
#22
Prev: #—
|
4.1 |
—
|
750,000 | — |
NEW
|
750,000 | $31,545,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 1.23% | 1.22% |
#23
4
Prev: #27
|
1.0 |
—
|
-491,756 | -4.6% |
P
S
|
10,144,562 | $27,288,872 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LXEO
LEXEO THERAPEUT...
|
Healthcare | 1.22% | 1.50% |
#24
4
Prev: #20
|
2.5 |
—
|
757,400 | 15.0% |
P
S
|
5,807,611 | $27,034,429 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.18% | 0.82% |
#25
9
Prev: #34
|
3.0 |
—
|
200,000 | 40.0% |
P
S
|
700,000 | $26,047,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BLTE
BELITE BIO INC
|
Healthcare | 1.15% | 0.54% |
#26
21
Prev: #47
|
3.5 |
—
|
100,000 | 153.8% |
P
S
|
165,000 | $25,407,525 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 1.15% | 1.19% |
#27
1
Prev: #28
|
1.0 |
—
|
-86,904 | -14.8% |
P
S
|
500,000 | $25,375,000 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
FBRX
FORTE BIOSCIENC...
|
Healthcare | 1.10% | 1.35% |
#28
4
Prev: #24
|
2.4 |
—
|
133,501 | 13.2% |
P
S
|
1,145,391 | $24,339,559 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
LLY
CALL
ELI LILLY & CO
|
CALL Option | 1.08% | — |
#29
Prev: #—
|
3.9 |
—
|
20,000 | — |
NEW
|
20,000 | $23,988,600 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 1.06% | 0.77% |
#30
6
Prev: #36
|
1.4 |
—
|
no change | no change |
P
S
|
967,620 | $23,474,461 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 1.01% | 0.58% |
#31
13
Prev: #44
|
3.4 |
—
|
350,000 | 70.0% |
P
S
|
850,000 | $22,431,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 0.97% | 1.49% |
#32
10
Prev: #22
|
0.4 |
—
|
-15,000 | -27.3% |
P
S
|
40,000 | $21,478,000 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.95% | 0.94% |
#33
Prev: #33
|
1.4 |
—
|
no change | no change |
P
S
|
172,125 | $21,099,083 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.91% | 1.05% |
#34
4
Prev: #30
|
1.4 |
—
|
no change | no change |
P
S
|
750,000 | $20,235,000 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.89% | 0.21% |
#35
46
Prev: #81
|
3.4 |
—
|
650,000 | 162.5% |
P
S
|
1,050,000 | $19,645,500 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 0.87% | 0.23% |
#36
36
Prev: #72
|
3.3 |
—
|
1,629,844 | 187.8% |
P
S
|
2,497,864 | $19,308,489 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 0.84% | 0.46% |
#37
17
Prev: #54
|
2.8 |
—
|
200,394 | 31.3% |
P
S
|
840,350 | $18,672,577 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.79% | 1.49% |
#38
17
Prev: #21
|
0.3 |
—
|
-300,000 | -40.0% |
P
S
|
450,000 | $17,415,000 | 2022 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TVTX
TRAVERE THERAPE...
|
Healthcare | 0.77% | 0.46% |
#39
16
Prev: #55
|
1.3 |
—
|
no change | no change |
P
S
|
300,000 | $17,043,000 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 0.72% | 0.57% |
#40
6
Prev: #46
|
2.3 |
—
|
94,500 | 12.1% |
P
S
|
875,760 | $15,947,590 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.70% | 0.71% |
#41
4
Prev: #37
|
1.3 |
—
|
no change | no change |
P
S
|
2,512,153 | $15,474,862 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IDYA
IDEAYA BIOSCIEN...
|
Healthcare | 0.67% | — |
#42
Prev: #—
|
3.8 |
—
|
400,000 | — |
NEW
|
400,000 | $14,908,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 0.65% | 0.68% |
#43
4
Prev: #39
|
2.8 |
—
|
1,050,000 | 33.2% |
P
S
|
4,214,582 | $14,371,725 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
ODYSSEY THERAPE...
|
|
Unknown | 0.65% | — |
#44
Prev: #—
|
3.8 |
—
|
766,346 | — |
NEW
|
766,346 | $14,338,334 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
N/A
COGENT BIOSCIEN...
|
|
Bond/Debt | 0.62% | 0.44% |
#45
12
Prev: #57
|
3.2 |
—
|
4,000,000 | 57.1% |
P
S
|
11,000,000 | $13,653,740 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
OMER
PUT
OMEROS CORP
|
PUT Option | 0.61% | — |
#46
Prev: #—
|
3.7 |
—
|
1,411,300 | — |
NEW
|
1,411,300 | $13,421,463 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
HELIX ACQUISITI...
|
|
Unknown | 0.60% | 0.66% |
#47
7
Prev: #40
|
1.2 |
—
|
no change | no change |
P
S
|
1,250,000 | $13,300,000 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
EQ
EQUILLIUM INC
|
Healthcare | 0.59% | 0.13% |
#48
44
Prev: #92
|
3.2 |
—
|
2,873,690 | 234.3% |
P
S
|
4,100,000 | $13,120,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ALKS
CALL
ALKERMES PLC
|
CALL Option | 0.59% | — |
#49
Prev: #—
|
3.7 |
—
|
250,000 | — |
NEW
|
250,000 | $13,098,750 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.57% | 0.29% |
#50
15
Prev: #65
|
2.7 |
—
|
48,013 | 48.0% |
P
S
|
148,013 | $12,700,996 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-50 of 131 holdings